Exchange: NASDAQ·Updated 08:18 PM EDT
NVAX logo

NVAX Novavax Inc

$9.48
$0.06
(0.64%)
Overnight
Prev Close $9.42
EarningsNov 5
Mkt Cap$1.55B
Vol6.12M

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
50

Neutral Sentiment

How do you feel about NVAX?

Advertisement|Remove ads.